Larissa Lempert, MD
Neurology · Brooklyn, NYNPI 1912182619
Payments from drug & device makers
Across 47 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$225
- Lundbeck LLC$169
- AbbVie$137
- Azurity Pharmaceuticals, Inc.$100
- Pfizer$76
- Amneal Pharmaceuticals LLC$61
- plus $260 from 9 others
What the payments were for
- Speaking & faculty fees$232%
- Food & beverage$1,00598%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $225 |
| Lundbeck LLC | 7 | $169 |
| AbbVie(2 entities) | 6 | $137 |
| Azurity Pharmaceuticals, Inc. | 6 | $100 |
| Pfizer | 3 | $76 |
| Amneal Pharmaceuticals LLC | 3 | $61 |
| MDD US Operations, LLC | 2 | $46 |
| Biogen | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Sanofi | 1 | $22 |
| Bristol Myers Squibb | 1 | $20 |
How this compares
$1,028 in reported general payments places this provider in the 45th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrileptalOxcarbazepine | 11 | $13,769 |
| Gabapentin | 323 | $1,218 |
| Donepezil Hcl | 110 | $640 |
| Memantine Hcl | 52 | $564 |
| Amitriptyline Hcl | 80 | $284 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 29 | $258 |
| Baclofen | 14 | $181 |
| Levetiracetam | 24 | $171 |
| Nortriptyline Hcl | 15 | $131 |
| Ibuprofen | 19 | $129 |
| Meclizine Hcl | 17 | $45 |
| Primidone | 11 | $40 |
| Diazepam | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other neurology in Brooklyn
- Idan SharonBrooklyn$2.1M
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.